Form 4: Macrogenics Executive Thomas Spitznagel Reports Stock Transactions
SEC Form 4 Filing
Senior VP Thomas Spitznagel reports the vesting and disposal of Macrogenics stock and restricted stock units.
Summary
- On February 15, 2025, Thomas Spitznagel, Senior VP of Technical Operations at Macrogenics Inc., reported transactions involving the company's stock.
- Spitznagel exercised 13,332 restricted stock units (RSUs) that vested on February 15, 2025, converting them into common stock.
- He then disposed of 5,520 shares of common stock at a price of $2.56 per share to cover tax obligations.
- Following these transactions, Spitznagel directly owns 21,402 shares of Macrogenics common stock and 13,332 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Future Outlook
The remaining restricted stock units will vest in subsequent years.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency into insider transactions, allowing investors to monitor the buying and selling activity of company executives and directors.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect routine executive compensation and tax obligations.
Key Dates
| Date | Description |
|---|---|
| 02/15/2023 | Reporting person was granted 40,000 restricted stock units. |
| 02/15/2024 | 33% of the restricted stock units vested. |
| 02/15/2025 | Date of reported transactions: vesting of RSUs and disposal of shares. |
| 02/19/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.